NeuroSense Therapeutics, Ltd. , a leading clinical-stage biotechnology company focused on developing treatments for severe neurodegenerative diseases, today announced that two members of its ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $75 ...

Out of all of the special options we uncovered, 7 are puts, for a total amount of $423,006, and 9 are calls, for a total ...

OKTA) options are showing a volume of 21,462 contracts thus far today. That number of contracts represents approximately 2.1 million underlying shares, working out to a sizeable 49.3% of OKTA's ...

In this article, we are going to take a look at where Okta, Inc. (NASDAQ ... such as a rebound in the global economic activity, demonstrating signs of a manufacturing recovery.

What Analysts Are Saying About Okta Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $116.0. Unusual Options Activity ...

In this article, we are going to take a look at where Okta, Inc. (NASDAQ ... While insider trading activity can provide valuable insights into a company’s future, it should be considered ...